Which statins can be co‑prescribed safely with amlodipine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Statins Safe to Use with Amlodipine

All statins can be safely co-prescribed with amlodipine, but atorvastatin, pitavastatin, rosuvastatin, fluvastatin, and pravastatin have no significant drug interactions and are preferred, while lovastatin and simvastatin require dose restrictions (≤20 mg daily for both). 11

Preferred Statins (No Dose Restrictions)

The following statins show no evidence of significant interaction with amlodipine and can be used at standard doses 11:

  • Atorvastatin - No significant interaction 22
  • Pitavastatin - No significant interaction
  • Rosuvastatin - No significant interaction
  • Fluvastatin - No significant interaction
  • Pravastatin - No significant interaction

These non-CYP3A4-metabolized statins (pravastatin, rosuvastatin, pitavastatin, fluvastatin) or minimally-interacting CYP3A4 statins (atorvastatin) are the safest choices when prescribing with amlodipine.

Statins Requiring Dose Limitations

Simvastatin and Lovastatin

Both require dose restrictions when combined with amlodipine due to minor but clinically relevant increases in statin exposure 11:

  • Simvastatin: Maximum 20 mg daily when co-administered with amlodipine 12
  • Lovastatin: Maximum 20 mg daily when co-administered with amlodipine 1

The FDA drug label explicitly states that amlodipine increases simvastatin exposure by 77%, necessitating the 20 mg daily dose limit 2. While pharmacokinetic data show only a "minor increase" in statin exposure with these combinations, the dose restrictions are mandated to minimize myopathy risk 11.

Clinical Reasoning

Why the difference? Amlodipine is a weak CYP3A4 inhibitor 22. Simvastatin and lovastatin undergo extensive first-pass metabolism via intestinal CYP3A4, making them particularly vulnerable to interactions 3. In contrast, atorvastatin has less intestinal first-pass metabolism, and the non-CYP3A4 statins bypass this pathway entirely 3.

Important Caveats

  • Asian patients: Exercise additional caution with any statin-calcium channel blocker combination, as they may have different pharmacogenetic profiles affecting drug metabolism 11
  • Patients already stable on higher doses of simvastatin or lovastatin with amlodipine without adverse effects may continue, but this should not be initiated in new patients 1
  • Monitor for myopathy symptoms (muscle pain, weakness) regardless of which statin is chosen, though risk is lowest with the preferred statins listed above

Practical Algorithm

  1. First choice: Use atorvastatin, rosuvastatin, pitavastatin, pravastatin, or fluvastatin at standard doses with amlodipine
  2. If simvastatin or lovastatin must be used: Limit to ≤20 mg daily
  3. If patient needs >20 mg simvastatin/lovastatin: Switch to a non-CYP3A4 statin (pravastatin, rosuvastatin, pitavastatin) 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.